Analgesia Nociception Index Monitoring in Trigeminal Cardiac Reflex During Nasal Septoplasty

ConditionENT Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorFayoum University Hospital

About this trial

This study aims to evaluate the utility of Analgesia Nociception Index (ANI) monitoring as a predictive and preventive tool for TCR during septoplasty. By comparing standard anesthetic monitoring with ANI-guided analgesia, this research seeks to determine whether maintaining optimal autonomic balance can reduce the incidence of trigeminal cardiac reflex (TCR) and improve intraoperative cardiovascular stability.

Eligibility criteria

Qualifiers

Age 18-60 years.

American society of anesthesiologist physical status I-II

Indicated for primary septoplasty.

Disqualifiers

Known cardiac arrhythmias or conduction disorders.

Use of beta-blockers or antiarrhythmic medications.

Previous nasal surgery and Combined nasal procedures.

Inability to obtain reliable Analgesia Nociception Index readings.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

90 Participants
are grouped into 2 trial groups

Sponsors and collaborators